microbial limit test of chinese pharmacopeiawp.chp.org.cn/upload/userfiles/20181205/...2018/12/05...
TRANSCRIPT
Microbial Limit Test of Chinese Pharmacopeia
Ma ShihongNational Institutes for Food and Drug Control
Date: Oct. 30, 2018, Beijing
NIFDC
Historical Revision1
Similarities and differences with ICH protocol2
Microbial Limit Test of Chinese Pharmacopeia
Challenges and developments3
NIFDC1. Historical Revision
NIFDC
Chinese Pharmacopoeia Major events
1995 Edition The microbial limit test was firstly included
2000 Edition The microbial limit standard was firstly included
2005 Edition The requirement for methodology verification was firstly included
2010 Edition The requirement for culture medium suitability test was firstly included
2015 Edition Generally in line with ICH Microbial Test Method
In 1978, the Ministry of Health issued the first Tentative Standard of Drug and Healthcare
In 1986, the Ministry of Health issued Standard of Drug and Healthcare
1. ChP Historical Revision
NIFDCHarmonization(USP/EP/JP)
The USP and the EP Microbial Limits Tests are in the final stages of harmonization. They were signed off to Stage6A at the November,2005 meeting of the PDG held in Chicago, IL USA (USP 2006a).Stage6A:REGIONAL ADOPTION
USP31 General Information/<1196> Pharmacopeial Harmonization: The following policy statement was approved by the PDG at its September 2002 meeting.Table2. Status of Harmonization-General ChaptersTests for specified microorganisms EP Stage4Microbial Enumeration EP Stage4Microbial Attributes EP Stage4Stage4:Official Inquiry
Harmonization Timing/IssuesEP:2007/01 USP:2009/05 JP:2007/10
NIFDC
Pharmacopeia USP/EP/JP/ChP2015 Edition of Chinese Pharmacopoeia before 2010
Classification basis Classification as per nutrition conditions Classification as per microbial species
Quality control classification Aerobes and anaerobes Bacteria and fungi
Testing system Directly corresponding to the culture conditions
Selecting culture or distinguish by macroscopic inspection
Evaluation Simple and strict Easily causing missed detection
——Systemic difference between microbial test of Chinese Pharmacopeia and foreign Pharmacopeia
1. ChP Historical Revision
NIFDC
Pharmacopeia Chp,2015 Edition Chp,2010 Edition
Classification Nutrition conditions Microbial species
Item 1Total count of aerobes, 3-5dPeptone agar/broth(TSA/B)
Bacterial count, 3dNutrient agar (NA)
Item 2Total count of mould and yeast, 5-7d
Sabouraud dextrose agar(SDA)Count of mould and yeast, 5d
Sodium rose bengal agar(RA)
1. ChP Historical Revision
Testing items and culture medium
NIFDC
Testing items and culture medium
No. Chp,2015 Edition Chp,2010 Edition
1* Cholate tolerant Gram negative bacteria Coli group
2* Escherichia coli Escherichia coli
3* Salmonella Salmonella
4* Pseudomonas aeruginosa Pseudomonas aeruginosa
5* Staphylococcus aureus Staphylococcus aureus
6 Clostridium Clostridium
7 Candida albicans Candida albicans
*: There is obvious change in the culture medium system.
1. ChP Historical Revision
NIFDC
Standard for microbial counting:
The retest is not compulsory, but the accuracy of the results is analyzed via the
laboratory investigation.
The limit standard is represented by exponential method, and maximum acceptable
limits follow the 2X standard:
101cfu: acceptable maximum limit is 20;
102cfu: acceptable maximum limit is 200; and so on.
Basic Characteristics of Pharmacopeia of 2015 Edition
1. ChP Historical Revision
NIFDC
Result interpretation of control bacteria:
The retest is not compulsory, but investigator and analyze the accuracy of the results via
the laboratory.
Fewer chemical tests or other appropriate methods used for further identification.
(Microscopic test, biochemistry, chromatography & spectrum technology and
molecular biology, etc.)
Basic Characteristics of Pharmacopeia of 2015 Edition
1. ChP Historical Revision
NIFDC
Requirements for laboratory environment:
(1105), (1106)
(9203) not lower than Grade B unidirectional flow against Grade D background
Basic Characteristics of Pharmacopeia of 2015 Edition
Be comprehensively in line with international standard;
Serving for drug microbes from final product test to process control.
1. ChP Historical Revision
NIFDC
USP35 Chinese Pharmacopoeia of 2015 Edition
<61>Microbiological Examination of NonsterileProducts: Microbial Enumeration Tests
(1105) Microbial limit test for non-sterile products: microbial count method
<62>Microbiological Examination of NonsterileProducts: Tests for Specified Microorganisms
(1106) Microbial limit test for non-sterile products: control bacteria test method
<1111>Microbiological Attributes of NonsterilePharmaceutical Product
(1107) Microbial limit standard for non-sterile drugs
2. Differences and Similarities with ICH Protocol
NIFDC
Formulation type TAMC TYMC Control bacteria
Solid/liquid via oral administration
103
102
102
101
Escherichia coli, no salmonella should be detected in chemical drug substance and organ extract
Via oral mucosa/gingiva/nasal cavity 102 101 Escherichia coli, staphylococcus aureus,
pseudomonas aeruginosa
Via ear/skin 102 101 Staphylococcus aureus, pseudomonas aeruginosa
Inhalation via respiratory tract 102 101
Escherichia coli, staphylococcus aureus, pseudomonas aeruginosa, cholate tolerant Gram-negative bacteria
Vagina/urinary tract 102 101 Staphylococcus aureus, pseudomonas aeruginosa, candida albicans, clostridium (TCM)
Solid/liquid via rectal medication
103
102
102
102 Staphylococcus aureus, pseudomonas aeruginosa
Other local medication 102 102 Staphylococcus aureus, pseudomonas aeruginosa
2. Differences and Similarities with ICH protocol
ChP compulsory standard and USP recommended standard!
NIFDC
USP<1111>Microbi
al test method
for non-sterile
products:
Microbial
standard for
reagents and
medicinal
materials
2. Differences and Similarities with ICH Protocol
NIFDC
Formulation type TAMC TYMC Control bacteria
Raw medicinal materials and excipients 103 102 *(Not specified in a unified
manner)
TCM extracts 103 102 *(Not specified in a unified manner)
TCM decoction slices *(Not specified in a unified manner)
*(Not specified in a unified manner)
Absence of salmonella in 10 g, and cholate tolerant Gram-negative bacteria should be lower than 104 cfu/g
2. Differences and Similarities with ICH Protocol
NIFDC
Escherichia coli〔CMCC(B) 44102〕 Bacillus subtilis 〔CMCC(B) 63501〕 ——ATCC 6633 Staphylococcus aureus〔CMCC(B) 26003〕——ATCC 6538P Salmonella paratyphi B〔CMCC(B) 50094〕 Pseudomonas aeruginosa〔CMCC(B) 10104〕 Clostridium sporogenes〔CMCC(B) 64941〕 Candida albicans [CMCC(F) 98001] ——ATCC10231 Aspergillus niger 〔CMCC(F) 98003〕
2. Differences and Similarities with ICH Protocol
Staphylococcus aureus〔Such as ATCC6538,NCIMB9518,CIP4.83, or NBRC13276〕Pseudomonas aeruginosa〔Such as ATCC9027, NCIMB8626, CIP82.118, or NBRC13275〕Escherichia coli〔Such as ATCC8739,NCIMB8545,CIP53.126, or NBRC3972〕
Salmonella enterica subsp. enterica serovar Typhimurium or, as an alternative, 〔Such as ATCC 14028〕Salmonella enteria〔Such as NBRC100797,NCTC6017, or CIP80.39〕Clostridium sporogenes such as ATCC 11437 (NBRC 14293, NCIMB 12343, CIP 100651) or ATCC 19404 (NCTC 532 or CIP 79.3).Candida albicans〔Such as ATCC10231,NCPF3179,IP48.72, or NBRC1594〕Aspergillus brasiliensis 〔Such as ATCC 16404,IMI149007, IP 1431.83, or NBRC 9455 〕
Differences in Standard Bacteria Strains
NIFDC
Properties of test sample:1. Water solubility or oiliness2. Antibacterial activity3. Strict standard
1. Pore size of the membrane: not greater than 0.45μm.
2. Diameter: 50/75 mm.
Membrane
material
Total rinsing volume not greater than 1000 mL
Membrane-filter Method
NIFDC
二级过滤的75mm薄膜过滤器专利
Membrane-filter Method
NIFDC
19
SDA and Sodium Rose Bengal Agar Culture Medium
coli aeruginosa aureus subtilis
Culture in nutritive agar culture medium at 35℃ for 48 hrs 75 81 91 79
Culture in sodium rose bengal agar culture medium at 35℃ for 48 hrs 57 47 0 0
Culture in sodium rose bengal agar culture medium at 25℃ for 72 hrs 45 41 0 0
Table. Results of specific experiment of sodium rose bengal agar culture medium
When there is severe bacterial contamination, the sodium rose bengal
agar culture medium can inhibit a portion of Gram positive bacteria.
NIFDC
Result interpretation of control bacteria testSeparation analysis for detected microbes: biochemical tests or other appropriate methods used for further identification. For example: Application of triple sugar iron agar in salmonella test
2. Differences and Similarities with ICH Protocol
NIFDC
www.themegallery.com
Guarantee Concept for Systematic Experiment Results
9203(13 items) WHO GPML(12 items)1 Personnel Personnel2 Media Reagents and culture media3 Reagents Reagents and culture media4 Species Reference materials and reference cultures5 Environment Environment6 Equipment Equipment7 Sample Sampling,Sample handling and identification8 Test method Validation of test methods9 Disposal of contaminated waste Disposal of contaminated waste10 Quality (result and test) Quality assurance of results and performance,Testing
procedures11 Experiment records12 Result interpretation and report Test reports13 Document /
NIFDC
How to control the quality of test system?USP/EP/ Chinese Pharmacopoeia 2010/2015 Edition——Culture medium suitability test
Culture Media
NIFDC
USP38:<61>Microbiological Examination of Nonsterile Products: Microbial
Enumeration Tests:Growth Pormotion of the Media。<62> Microbiological
Examination of Nonsterile Products: Tests for Specified Microorganisms:Growth
Promotion and Inhibitory Properties of the Media. Test each batch of ready-prepared
medium and each batch of medium prepared either from dehydrated medium or from
ingredients. For a freshly prepared inoculum, growth of the microorganisms
comparable to that previously obtained with a previously tested and approved
batch of medium occurs.
Culture Medium Suitability Test
NIFDC
24
USP: compare to that previously obtained with a previously tested and approved batch of medium occurs.
The Drug Microbial Laboratories in China are small and dispersed, and thousands of enterprises
and basic-level drug test institutions can hardly effectively carry out reference culture medium
verification and evaluation;
In the inspection, it is difficult to evaluate the verification of reference culture medium by the
microbial laboratory of an enterprise.
Culture Medium Suitability Test
ChP: control culture medium
NIFDC
Quality control of culture medium:
USP—Previously verified culture medium
Chinese Pharmacopoeia —Control culture medium
Ma Shihong, Yang Meiqin, Liu Peng, Cao Limei, Hu Changqin (National Institutes for Food and Drug Control, Beijing, 100050)Development and application of control culture medium in Chinese Pharmacopoeia of 2010 version, Chinese Pharmaceutical Affairs, 2012(8)
Control culture medium
•National Institutes for Food and Drug Control studied the supply according to national standard material procedurePatent number of single-dose separate package free from weighing: ZL200920108836.8
NIFDCControl Culture
Medium
WWW.nifdc.org.cnStandard substance
query
Standard substance supply
NIFDC3.Challenges and Developments
TCM accounts for a large portion in the constitution of Chinese Drugs, and its
microbial characteristics bring huge challenges to the ICH protocol.
NIFDCCasesCase: The standard bacteria count for radix isatidis granules should not be greater than 1000cfu/g, and that of a certain radix isatidis granules tested by a drug testing institution was 1200cfu/g, which was submitted to National Institutes for Food and Drug Control for arbitration.
Note: Method suitability
Qualified Unqualified
Plating method (1: 10 test solution) 1 mL/plate 0.5 mL/plate 0.2 mL/plate
Counting result (cfu/g) 650 910 1380
NIFDC
Vigorous SDA bacterial growth brings challenges to result interpretation.
3.Challenges and Development
If bacterial growth makes the TYMC result not conforming to the
requirements of microbial limit, “SDA + antibiotics” can be used for
re-counting.
TYMC>TAMC
What to do if SDA first count exceeds TAMCstandard?
NIFDC
Data rounding, full data comparison, and uncertainties of microbial results
3.Challenges and Development
No. Batch No. Original test results Retest results Retest conclusion1 171006 2400 20 Conformed2 171005 260 Lower than 10 Conformed3 180303 1700 120 Conformed4 171101 6200 21000 Non-conformed5 171101 2300 Lower than 10 Conformed6 180203 770 1100 Non-conformed7 180201 1900 2200 Non-conformed8 180304 3400 4600 Non-conformed9 180203 3700 9500 Non-conformed
Table Test results of 9 batches of retest samples of an oral solution (standard: the total count of aerobes should not be greater than 200 cfu/mL)
According to the Clause 26, Chapter 4, drug surveillance market [2006] No. 379
Management Rules for Drug Quality Spot Check, “(II) The samples obviously non-
uniform or lower than the amount needed for test” will not be accepted for retest.
NIFDC
Control bacteria test results led to the evaluation and
assessment of large amount of objectionable microorganism
3. Challenges and Development
In 2018, microbial limit test was performed for 298 batches of a pediatric coughing and asthma TCM granules produced by 61 enterprises, in which the total count of aerobes, and total count of mould and yeast all conformed to the requirements; after the test of E. coli was qualified, suspected bacterial colonies was detected in the control bacteria test of 15 samples, in which A. baumanii was detected in 12 samples, and pantoeawas detected in 3 samples, and both are human conditioned pathogen, in which A. baumanii is an important pathogen in hospital infection.
Objectionable Microorganisms!
NIFDC
Whether it is pathogenic bacteria? Various domestic and foreign
standards Authoritative textbook and brochure Authoritative literature report. FDA: Bad Bug Book
NIFDCMicrobial Limit Test of Chinese Pharmacopeia
ChP2015ICH
EvaluationUSP40 EP JP17
(1105)Microbial limit test for non-sterile products: Microbial Enumeration Tests
<61>Microbiological examination of nonsterile products: Microbial Enumeration Tests
2.6.12 4.05
Basically consistent: There are differences only in some verified bacterial strains, control culture medium and operation details, etc.; however, due to relatively high load of TCM microbes, there is quit a challenge in the implementation of ChP.
(1106)Microbial limit test for non-sterile products: Control Bacteria Test Method
<62>Microbiological Examination of nonsterile products: Tests for Specifiedmicroorganisms
2.6.13 4.05
Basically consistent: There are differences only in some verified bacterial strains, control culture medium,operation details and result interpretation, etc.; however, due to the characteristics of TCM contamination, there is quit a challenge in the implementation of ChP.
(1107)Microbial limit standard for non-sterile drugs
<1111>Microbiological Examination ofNon-sterile products: acceptance criteriafor pharmaceutical preparations andsubstances for pharmaceutical use
5.1.4 5.
Partially consistent: There are significant differences in the practical scope, salmonella test requirements, microbial limit standard for small and micro dose, such as patch, TCM (plant drug) standard, etc.
On the whole, the ChP Microbial Limit Test of 2015 edition is basically consistent with the ICH protocol in the test method, test procedure, experiment requirements, standard characterization method, etc.; due to the specificity of TCM, the ChP of 2015 edition has relatively high challenge in the implementation, and the TCM standard should be fully studied in the future, and further coordination with ICH protocol should be further studied and discussed.
NIFDC
Microbiology Laboratory of China Institute for Food and Drug Control (Old Address of Temple of Heaven )Institute for Chemical Drug ControlNational Institutes for Food and Drug ControlMicrobiology Lab Add: No.2 Tiantan Xili, Beijing, 10050 P.R.China
NIFDC Temple of Heaven (Old Address)
NIFDC Da Xing (New Address)